BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23265388)

  • 1. Reply from Authors re: Ching-Shwun Lin, Tom F. Lue. Adipose-derived Stem Cells for the Treatment of Peyronie's Disease? Eur Urol 2013;63:561-2: Xenogeneic Adipose Stem Cell Treatment in a Rat Model of Peyronie's Disease.
    Castiglione F; Hedlund P; Van der Aa F; Bivalacqua TJ; Rigatti P; Van Poppel H; Montorsi F; De Ridder D; Albersen M
    Eur Urol; 2013 Mar; 63(3):563-4. PubMed ID: 23265388
    [No Abstract]   [Full Text] [Related]  

  • 2. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease.
    Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Kim H; Trost LW; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
    Andrology; 2014 Mar; 2(2):244-51. PubMed ID: 24574095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-derived stem cells for the treatment of Peyronie's disease?
    Lin CS; Lue TF
    Eur Urol; 2013 Mar; 63(3):561-2. PubMed ID: 23149148
    [No Abstract]   [Full Text] [Related]  

  • 4. Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis.
    Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Braun SE; Kim H; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
    J Sex Med; 2015 Jul; 12(7):1533-44. PubMed ID: 26062100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.
    Castiglione F; Hedlund P; Van der Aa F; Bivalacqua TJ; Rigatti P; Van Poppel H; Montorsi F; De Ridder D; Albersen M
    Eur Urol; 2013 Mar; 63(3):551-60. PubMed ID: 23040209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracorporeal shockwave therapy for erectile dysfunction and Peyronie's disease].
    Zhu JY; Jiang R
    Zhonghua Nan Ke Xue; 2014 Sep; 20(9):846-9. PubMed ID: 25306816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biotherapies for erectile dysfunction and Peyronie's disease: Where are we now?].
    Akakpo W; Schirmann A; Ferretti L; Ben-Naoum K; Carnicelli D; Graziana JP; Hupertan V; Madec FX; Marcelli F; Methorst C; Morel-Journel N; Savareux L; Terrier JE; Faix A; Huyghe E; Yiou R
    Prog Urol; 2020 Dec; 30(16):1000-1013. PubMed ID: 32826194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease.
    Kalsi J; Minhas S; Christopher N; Ralph D
    BJU Int; 2005 May; 95(7):1029-33. PubMed ID: 15839925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
    Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
    Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Office-based management of impotence and Peyronie's disease.
    Tapscott AH; Hakim LS
    Urol Clin North Am; 2013 Nov; 40(4):521-43. PubMed ID: 24182973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies.
    Haney NM; Gabrielson A; Kohn TP; Hellstrom WJG
    Sex Med Rev; 2019 Apr; 7(2):313-320. PubMed ID: 29960873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy for the treatment of Peyronie's disease.
    Dellis A; Papatsoris A
    Expert Opin Biol Ther; 2017 Apr; 17(4):407-413. PubMed ID: 28274142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual dysfunction: The potential of stem cell therapy for Peyronie disease.
    Shindel AW
    Nat Rev Urol; 2013 Jan; 10(1):8-9. PubMed ID: 23165398
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury.
    You D; Jang MJ; Lee J; Suh N; Jeong IG; Sohn DW; Kim SW; Ahn TY; Kim CS
    Prostate; 2013 Feb; 73(3):278-86. PubMed ID: 22821215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of peyronie's disease (author's transl)].
    Hasche-Klünder R; Tudoriu T
    Urologe A; 1978 Jul; 17(4):232-5. PubMed ID: 684991
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surgical treatment of erectile dysfunction in Peyronie's disease].
    Tarasov NI; Bavil'skiĭ VF; Plaksin OF; Kondrat'ev LN
    Urologiia; 2001; (6):35-40. PubMed ID: 11785080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peyronie's disease. Our therapeutic experience. Apropos of 182 cases].
    Reziciner S; Doremieux J; Grinenwald P
    Ann Urol (Paris); 1987; 21(6):425-8. PubMed ID: 3435062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in stem cell therapy for erectile dysfunction.
    Gur S; Abdel-Mageed AB; Sikka SC; Hellstrom WJG
    Expert Opin Biol Ther; 2018 Nov; 18(11):1137-1150. PubMed ID: 30301368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.